Clinical trials: Reticular Pseudodrusen
AMD, Soft Drusen
Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.
A pilot study to establish the efficacy and safety of supplementation with postbiotics in patients with macular degeneration.
- Conditions
- AMD, Soft Drusen, Reticular Pseudodrusen, Drusen Stage Macular Degeneration
- Trial name
- REVERS (NCT05056025)
- Testing
- Postbotics and Vitamins, Vitamins
- Where
- Spain
- Volunteers
- 48 people
- Sponsor
- Institut de la Macula y la Retina
Reticular Pseudodrusen (RPD), Age-Related Macular Degeneration
Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation
Background: Age-related macular degeneration (AMD) is an eye disease. It is the leading cause of vision loss in people over 55 in the U.S. Changes in the eye can make it difficult for they eye to adjust to low light.
- Trial name
- NCT03478878
- Testing
- Vitamin A Palmitate
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- National Eye Institute (NEI)
Age-Related Macular Degeneration
AMD Ryan Initiative Study (ARIS)
Objective: To learn more about AMD. Eligibility: People ages 55 and older with any of the following: Early AMD RPD Healthy eyes Design: Participants will be screened with: Eye exam: The pupil will be dilated with eye drops.
- Trial name
- NCT03092492
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- National Eye Institute (NEI)
AMD - Age-Related Macular Degeneration
Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration
This study evaluates whether a low-energy laser treatment called photobiomodulation (PBM) can improve visual function and retinal structure in patients with age-related macular degeneration (AMD) who have reticular pseudodrusen.
- Trial name
- PBM in iAMD (NCT07554690)
- Testing
- Photobiomodulation Therapy
- Where
- Italy
- Volunteers
- 67 people
- Sponsor
- Fondazione G.B. Bietti, IRCCS
Age-related Macular Degeneration
Reticular Pseudodrusen Progression Study
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrial countries. Reticular pseudodrusen (RPD) have been recognized as an additional phenotypic characteristic frequently observed in…
- Trial name
- NCT02345317
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- University Hospital Muenster
Age Related Macular Degeneration
A Snapshot Adaptive Optics and Hyperspectral Autofluorescence Fundus Camera for Age-Related Macular Degeneration (AMD)
This study proposes to use a new instrument (AO-OCT/AF: adaptive optics - optical coherence tomography/autofluorescence) combined with a data processing method to image the retinal pigment epithelium (RPE) of the eye in normal…
- Trial name
- NCT03963817
- Testing
- adaptive optics AO-OCT/AF instrument
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Icahn School of Medicine at Mount Sinai
AMD
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
Background: Age-related macular degeneration (AMD) is an eye disease. It is the leading cause of vision loss in people over 55 in the U.S. Changes in the eye can make it difficult for the eye to adjust to low light.
- Trial name
- NCT03478865
- Testing
- Vitamin A palmitate
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- National Eye Institute (NEI)
Age-Related Macular Degeneration, Geographic Atrophy
Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD
To evaluate the effectiveness of subthreshold laser treatment on retinal sensitivity in patients with reticular pseudodrusen and incipient Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD).
- Conditions
- Age-Related Macular Degeneration, Geographic Atrophy, Reticular Pseudodrusen
- Trial name
- NCT02800356
- Testing
- Subthreshold 577 nm yellow wavelength laser photo-coagulator
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- Ospedale San Raffaele
Intermediate Age-Related Macular Degeneration With Reticular Pseudodrusen
Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study
There is limited data available on the efficacy and safety of Transscleral Lutein Iontophoresis (TSLI) in patients with in-termediate age-related macular degeneration (iAMD) and reticular pseudodrusen (RPD).
- Trial name
- NCT07420361
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- Mario Damiano Toro
Macular Degeneration, Senile, Laser Burn of Retina
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
Prospective, randomized, controlled, longitudinal, interventional multicentric study involving patients with reticular pseudodrusen secondary to AMD.
- Conditions
- Macular Degeneration, Senile, Laser Burn of Retina, Macular Degeneration Intermediate, Macular Degeneration, Dry
- Trial name
- PASCAL-RPD (NCT04847635)
- Testing
- Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)
- Where
- 3 sites in Italy
- Volunteers
- 50 people
- Sponsor
- Ospedale San Raffaele